MEKOPHAR Chemical Pharmaceutical Joint Stock Company
MEKOPHAR Chemical Pharmaceutical Joint Stock Company, commonly referred to as MEKOPHAR, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1977, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, primarily focusing on generic medicines and active pharmaceutical ingredients (APIs). With a strong operational presence across various regions in Vietnam, MEKOPHAR is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of medications that cater to various therapeutic areas, setting it apart through rigorous quality control and adherence to international standards. Recognised for its market leadership, MEKOPHAR has achieved notable milestones, including certifications from global health authorities, which underscore its dedication to excellence in the pharmaceutical sector.
DitchCarbon Score
How does MEKOPHAR Chemical Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MEKOPHAR Chemical Pharmaceutical Joint Stock Company's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MEKOPHAR Chemical Pharmaceutical Joint Stock Company's reported carbon emissions
MEKOPHAR Chemical Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As of now, MEKOPHAR has not inherited any emissions data from a parent or related organization, nor does it participate in any industry-standard initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate commitments. However, without specific emissions data or reduction initiatives, MEKOPHAR's current climate impact and future commitments remain unclear.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MEKOPHAR Chemical Pharmaceutical Joint Stock Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
